HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Indrajit Roy Selected Research

ormosil

11/2019Gold Nanoparticle-Enhanced Photodynamic Therapy from Photosensitiser-Entrapped Ormosil Nanoparticles.
1/2012Synthesis, surface modification, characterization, and biomedical in vitro applications of organically modified silica (ORMOSIL) nanoparticles.
9/2007Organically modified silica nanoparticles with covalently incorporated photosensitizer for photodynamic therapy of cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Indrajit Roy Research Topics

Disease

30Neoplasms (Cancer)
06/2022 - 07/2003
13Pancreatic Neoplasms (Pancreatic Cancer)
11/2019 - 03/2007
2Bacterial Infections (Bacterial Infection)
06/2022 - 01/2020
2Hyperthermia
08/2020 - 01/2020
2Brain Diseases (Brain Disorder)
11/2013 - 04/2009
2Neuroinflammatory Diseases
01/2012 - 07/2009
2Parkinson Disease (Parkinson's Disease)
10/2005 - 08/2005
1Hypoxia (Hypoxemia)
06/2022
1Obstructive Lung Diseases (Obstructive Lung Disease)
11/2016
1Lung Diseases (Lung Disease)
11/2016
1Inflammation (Inflammations)
11/2016
1Squamous Cell Carcinoma of Head and Neck
02/2012
1Head and Neck Neoplasms (Head and Neck Cancer)
02/2012
1Neurocognitive Disorders (Clerambault Syndrome)
01/2012
1Glioma (Gliomas)
04/2011
1Neuroblastoma
12/2010
1Cystic Fibrosis (Mucoviscidosis)
09/2010
1Dementia (Dementias)
07/2009
1Acquired Immunodeficiency Syndrome (AIDS)
07/2009
1Brain Ischemia (Cerebral Ischemia)
07/2009
1Esophageal Neoplasms (Esophageal Cancer)
06/2009
1Substance-Related Disorders (Drug Abuse)
04/2009
1Prostatic Neoplasms (Prostate Cancer)
03/2008

Drug/Important Bio-Agent (IBA)

12Pharmaceutical PreparationsIBA
06/2022 - 07/2003
8MicellesIBA
01/2012 - 05/2008
5Biological ProductsIBA
01/2022 - 08/2005
5GoldIBA
02/2012 - 01/2009
4LigandsIBA
04/2011 - 03/2007
4Peptides (Polypeptides)IBA
12/2010 - 03/2008
4Transferrin (beta 2 Transferrin)IBA
07/2010 - 03/2007
3ormosilIBA
11/2019 - 09/2007
3Photosensitizing Agents (Photosensitizers)IBA
05/2019 - 09/2007
3Contrast MediaIBA
01/2013 - 06/2007
3CadmiumIBA
06/2011 - 03/2009
3SiliconIBA
06/2011 - 05/2008
3IntegrinsIBA
04/2011 - 03/2009
3cyclic arginine-glycine-aspartic acid peptideIBA
10/2010 - 03/2009
3Monoclonal AntibodiesIBA
03/2009 - 06/2007
2Small Interfering RNA (siRNA)IBA
02/2012 - 04/2009
2Poloxamer (Poloxamer 407)IBA
01/2012 - 04/2011
2Arginine (L-Arginine)FDA Link
04/2011 - 03/2011
2MesothelinIBA
04/2011 - 03/2008
2Phospholipids (Phosphatides)FDA LinkGeneric
10/2010 - 03/2009
1RadiopharmaceuticalsIBA
01/2022
1Radioisotopes (Radionuclides)IBA
01/2022
1Anti-Bacterial Agents (Antibiotics)IBA
01/2020
1Methylene Blue (Methylthioninium Chloride)FDA Link
05/2019
1CopperIBA
05/2019
1Antineoplastic Agents (Antineoplastics)IBA
05/2019
1Gallic AcidIBA
05/2019
1Metal-Organic FrameworksIBA
05/2019
1Caseins (Casein)FDA Link
01/2019
1Nanoparticle Drug Delivery SystemIBA
11/2016
1Ibuprofen (Motrin)FDA LinkGeneric
11/2016
1sphingosine kinaseIBA
02/2012
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2012
1Claudin-5IBA
01/2012
1OccludinIBA
01/2012
1DNA (Deoxyribonucleic Acid)IBA
01/2012
1Proteins (Proteins, Gene)FDA Link
01/2012
1Aspartic Acid (Aspartate)FDA Link
04/2011
1Glycine (Aminoacetic Acid)FDA LinkGeneric
04/2011
1UCON 50-HB-5100 (F127)IBA
04/2011
1AcidsIBA
03/2011
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
12/2010
1Coloring Agents (Dyes)IBA
08/2010
1PolyelectrolytesIBA
07/2010
1Hydrochloric Acid (Hydrogen Chloride)FDA Link
07/2010
1Silver NitrateIBA
07/2010
1aspartic acid glycine arginineIBA
04/2010
1Matrix Metalloproteinases (MMPs)IBA
07/2009
1Metalloproteases (Metalloproteinases)IBA
07/2009
1Cysteine (L-Cysteine)FDA Link
06/2009
1AntigensIBA
03/2009
1SilverIBA
01/2009
1AminesIBA
03/2008
1cyclopamineIBA
03/2008
1Prostate-Specific Antigen (Semenogelase)IBA
03/2008
1ProdrugsIBA
03/2008
1Claudin-4IBA
03/2008
1Silicon Dioxide (Silica)FDA LinkGeneric
09/2007
11-phenyl-3,3-dimethyltriazene (PDT)IBA
09/2007
1GemcitabineFDA Link
03/2007
1Inhibitor of Apoptosis ProteinsIBA
03/2007
1X-Linked Inhibitor of Apoptosis ProteinIBA
03/2007
1AgarIBA
03/2007
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2007
1AntimetabolitesIBA
03/2007

Therapy/Procedure

14Quantum Dots (Quantum Dot)
11/2013 - 06/2007
11Therapeutics
01/2022 - 08/2005
4Precision Medicine
09/2020 - 04/2010
3Radiotherapy
01/2022 - 03/2007
3Photochemotherapy (Photodynamic Therapy)
01/2012 - 07/2003
2Lasers (Laser)
08/2020 - 12/2010
2Intravenous Injections
01/2012 - 04/2011
1Semiconductor Lasers
01/2020
1Drug Therapy (Chemotherapy)
01/2012
1Highly Active Antiretroviral Therapy (HAART)
01/2012
1Nanospheres
01/2011
1Semiconductors
03/2009